AstraZeneca Financial Ratios
NYSE: AZNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
AstraZeneca ratio analysis
AstraZeneca earned a net margin of 17.4% in FY 2025, up from 13.0% a year earlier. Gross margin was 81.9% compared with a median of 80.1% over the prior 9 years. Return on equity reached 21.0%, meaning AstraZeneca generated 0.21 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.57 versus 0.71 the year before, and the current ratio was 0.94. At the end of FY 2025, AZN traded at 28.0 times earnings; across the 10 fiscal years shown, its year-end P/E ranged from 19.8 to 1456.3, with a median of 38.2. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
AstraZeneca financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 28.00 | 29.44 | 35.35 | 64.27 | 1,456.25 | 40.98 | 97.26 | 46.09 | 29.28 | 19.80 |
| Price / sales | 4.83 | 3.80 | 4.55 | 4.73 | 4.42 | 4.93 | 5.35 | 4.49 | 3.91 | 3.00 |
| Price / book | 5.83 | 5.04 | 5.33 | 5.67 | 4.21 | 8.40 | 9.93 | 7.96 | 5.87 | 4.65 |
| Gross margin | 81.9% | 81.1% | 82.0% | 72.1% | 66.8% | 80.1% | 79.8% | 77.7% | 80.8% | 82.1% |
| Operating margin | 23.4% | 18.5% | 17.9% | 8.5% | 2.8% | 19.4% | 12.0% | 15.3% | 16.4% | 21.3% |
| Net margin | 17.4% | 13.0% | 13.0% | 7.4% | 0.3% | 12.0% | 5.5% | 9.8% | 13.4% | 15.2% |
| Free cash flow margin | 20.0% | 18.4% | 19.6% | 19.7% | 13.0% | 14.4% | 8.2% | 7.1% | 10.0% | 11.7% |
| Return on equity (ROE) | 21.0% | 17.2% | 15.2% | 8.9% | 0.3% | 20.5% | 10.2% | 17.3% | 20.1% | 23.6% |
| Return on assets (ROA) | 9.0% | 6.8% | 5.9% | 3.4% | 0.1% | 4.8% | 2.2% | 3.6% | 4.7% | 5.6% |
| Debt / equity | 0.57 | 0.71 | 0.70 | 0.76 | 0.76 | 1.26 | 1.34 | 1.53 | 1.19 | 1.13 |
| Current ratio | 0.94 | 0.93 | 0.82 | 0.86 | 1.16 | 0.96 | 0.86 | 0.96 | 0.80 | 0.87 |
| Revenue growth | 8.6% | 18.0% | 3.3% | 18.5% | 40.6% | 9.2% | 10.4% | -1.7% | -2.3% | -6.9% |
| EPS growth | 45.3% | 18.1% | 80.6% | 2,537.5% | -96.7% | 136.9% | -39.4% | -28.3% | -14.1% | 23.8% |